Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?

Hsin Hua Chen, Der Yuan Chen, Yi Ming Chen, Chao Hsiun Tang

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science